Sphingosine kinase 1 and pulmonary hypertension

Pyne, Nigel (Principal Investigator)
Pyne, Susan (Co-investigator)

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Project: Research

Status	Finished
Effective start/end date	1/09/12 → 31/08/15

Funding

British Heart Foundation BHF: £183,012.00

Related content

Research Output

Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodeling in a hypoxic model of pulmonary arterial hypertension

Research output: Contribution to journal › Article